|
Prevalence (%) of clinical parameters based on data from 1 references describing 6 individuals
Add new symptom/sign to this disease
List of symptoms
Symptom/sign |
Organ system |
Percent affected |
Pubmed id |
Added on(yyyy-mm-dd) |
Edit/add reference |
Mental retardation |
nervous |
100 % |
19138766 |
2024-05-01 |
|
Hypotonia |
nervous |
100 % |
19138766 |
2024-05-01 |
|
non-walking |
nervous |
100 % |
19138766 |
2024-05-01 |
|
Myopathy |
nervous |
100 % |
19138766 |
2024-05-01 |
|
Muscle hypertrophy |
skeletal |
83 % |
19138766 |
2024-05-01 |
|
Increased blood CK |
circulatory |
83 % |
19138766 |
2024-06-14 |
|
Cerebellar atrophy |
nervous |
50 % |
19138766 |
2024-05-01 |
|
Cerebral atrophy |
nervous |
50 % |
19138766 |
2024-05-01 |
|
Microcephaly |
nervous |
33 % |
19138766 |
2024-05-01 |
|
Leukodystrophy |
nervous |
33 % |
19138766 |
2024-05-01 |
|
Visual impairment |
nervous |
33 % |
19138766 |
2024-05-01 |
|
Seizures |
nervous |
17 % |
19138766 |
2024-05-01 |
|
Cleft lip or palate |
integumentary |
17 % |
19138766 |
2024-05-01 |
|
List of references:
POMT2 intragenic deletions and splicing abnormalities causing congenital muscular dystrophy with mental retardation. Akiko Yanagisawa, Céline Bouchet, Susana Quijano-Roy, Sandrine Vuillaumier-Barrot, Nigel Clarke, Sylvie Odent, Diana Rodriguez, Norma B Romero, Makiko Osawa, Tamao Endo, Ana Lia Taratuto, Nathalie Seta, Pascale Guicheney,
European journal of medical genetics - 2009
|